Advancing Cancer Care Equity for LGBTQ+ Individuals
Published
From the Duke Cancer Institute archives. Content may be out of date.
This month the DCI Community Outreach, Engagement, and Equity program and the National LGBT Cancer Network co-hosted a community conversation on "Equitable Spaces: Advancing Equity for LGBTQ+ Individuals in Cancer Care Treatment."
"It is our hope that this event provides necessary information and resources as well as sparks dialogue within and outside of the community to improve overall health outcomes for this community," read an opening slide for the event.
Two members of the LGBTQ+ community spoke about ways to make healthcare spaces more inclusive for all, Paul Chambers Raney:
Paula Chambers Raney has served as a FightCRC ambassador since 2019 and is a colorectal cancer awareness advocate focused on minorities in the Houston LGBTQ+ community. She is a wife, a Metallica fan, and a stage III colon cancer survivor.
Scout, MA, PhDis the executive director of the National LGBT Cancer Network, is principle investigator of both the CDC-funded LGBTQ tobacco-related cancer disparity network and OUT: The National Cancer Survey. Scout has faculty appointments at both Brown University and Boston Universities’ Schools of Public Health. He is a member of the NIH Council of Councils, the Co-Chair of the NIH Sexual and Gender Minority Research Office Work Group, on the Advisory Panel for NIH’s All of Us initiative, and a U.S. Pharmacopeial Convention delegate. Scout is an openly transgender father of three a vegetarian, an avid hiker and runner.
The webinar was moderated by Shaun Jones, a second-year MPH student in Applied Epidemiology at UNC Gillings School of Global Public Health.
Written By
Julie Poucher Harbin
Senior Writer, Duke Cancer Institute
Topics
Related News
MaryAnn Black Symposium Centers Health Equity in 2nd Annual Community Event
In January 2024, Duke University launched a celebration of its centennial — a historic opportunity to recognize Duke’s extraordinary past, communicate the impact of the present, and look toward Duke's potential impact going forward.Duke Cancer Institute, which recently celebrated its 50th anniversary as a National Cancer Institute-Designated Comprehensive Cancer Center, is proud to have hosted one of the Duke Centennial Celebration's signature events — the 2nd annual MaryAnn Black Distinguished Health Equity Symposium in honor of the late MaryAnn Black.
Duke Cancer Institute Blog
Article
Searching For & Finding Cancers' Achilles Heels: The Eighth Annual DCI Scientific Retreat Was One for the Books
The Duke Cancer Institute 8th Annual Scientific Retreat, held on December 3, 2021, attracted a broad array of faculty, trainees (students, residents, fellows, postdocs, etc.) and staff.For a second year, the retreat was entirely virtual and there were no poster presentations owing to the ongoing Covid-19 pandemic.“Hopefully, this will be the last time that we have to do it this way,” said executive director of DCI, Michael Kastan, MD, PhD, welcoming participants over Zoom.That it was virtual didn't stop a series of lively discussions from moving full-steam ahead on a full Friday afternoon on topics such as DCI cancer health equity and engagement strategies, viral lymphomas, bone loss as a CLL co-morbidity, ways around immune system evasion, cardio-protective cancer therapy, new approaches for treating head and neck squamous cell carcinoma, clues as to how cystic lesions progress to pancreatic cancer, unlocking immune dysfunction in glioblastoma, cholesterol-control drugs and cancer, and the PARP revolution.“We have a very full agenda today with great science from Duke trainees and faculty and are also celebrating several different anniversaries. First, it's my 10th anniversary as director of the Duke Cancer Institute and I have to say it's been a real privilege of my life to be in this role and to be able to work with such extraordinary people here. And I couldn't be more proud of everything that all the staff and all the faculty have done during the time that I've been here," said Kastan. "We're also celebrating the 50th anniversary of the National Cancer Act, which was signed in 1971, and put us down the path to NCI-designated cancer centers. The Duke Comprehensive Cancer Center (now DCI) was one of the original eight."Kastan also noted that DCI's own 50th was on the horizon."This year we begin celebrating our 50th anniversary. We've made a tremendous impact on cancer research and patient care in the U.S. and around the world.”
Duke Cancer Institute Blog
Related News
MaryAnn Black Symposium Centers Health Equity in 2nd Annual Community Event
In January 2024, Duke University launched a celebration of its centennial — a historic opportunity to recognize Duke’s extraordinary past, communicate the impact of the present, and look toward Duke's potential impact going forward.Duke Cancer Institute, which recently celebrated its 50th anniversary as a National Cancer Institute-Designated Comprehensive Cancer Center, is proud to have hosted one of the Duke Centennial Celebration's signature events — the 2nd annual MaryAnn Black Distinguished Health Equity Symposium in honor of the late MaryAnn Black.
Duke Cancer Institute Blog
Article
Searching For & Finding Cancers' Achilles Heels: The Eighth Annual DCI Scientific Retreat Was One for the Books
The Duke Cancer Institute 8th Annual Scientific Retreat, held on December 3, 2021, attracted a broad array of faculty, trainees (students, residents, fellows, postdocs, etc.) and staff.For a second year, the retreat was entirely virtual and there were no poster presentations owing to the ongoing Covid-19 pandemic.“Hopefully, this will be the last time that we have to do it this way,” said executive director of DCI, Michael Kastan, MD, PhD, welcoming participants over Zoom.That it was virtual didn't stop a series of lively discussions from moving full-steam ahead on a full Friday afternoon on topics such as DCI cancer health equity and engagement strategies, viral lymphomas, bone loss as a CLL co-morbidity, ways around immune system evasion, cardio-protective cancer therapy, new approaches for treating head and neck squamous cell carcinoma, clues as to how cystic lesions progress to pancreatic cancer, unlocking immune dysfunction in glioblastoma, cholesterol-control drugs and cancer, and the PARP revolution.“We have a very full agenda today with great science from Duke trainees and faculty and are also celebrating several different anniversaries. First, it's my 10th anniversary as director of the Duke Cancer Institute and I have to say it's been a real privilege of my life to be in this role and to be able to work with such extraordinary people here. And I couldn't be more proud of everything that all the staff and all the faculty have done during the time that I've been here," said Kastan. "We're also celebrating the 50th anniversary of the National Cancer Act, which was signed in 1971, and put us down the path to NCI-designated cancer centers. The Duke Comprehensive Cancer Center (now DCI) was one of the original eight."Kastan also noted that DCI's own 50th was on the horizon."This year we begin celebrating our 50th anniversary. We've made a tremendous impact on cancer research and patient care in the U.S. and around the world.”
Duke Cancer Institute Blog
This page was reviewed
on 07/13/2022